VeriMommorus bombycis root extract은 임신 중 안전한가요?
No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR reproductive safety restriction was identified for Morus bombycis (mulberry) root extract, and there are no consistent peer‑reviewed reports showing developmental or reproductive toxicity from topical use; regulatory databases (CosIng, PubChem) list this as a botanical extract without reproductive hazard labels. Therefore default no evidence of reproductive hazard (h=0), no established reproductive mechanism (m=0), and negligible dermal exposure expected for typical cosmetic use (e=0). Sources: ECHA Annex VI (no harmonised classification), CosIng, PubChem, PubMed.
Pregnancy-safe products containing morus bombycis root extract
Related ingredients
Frequently asked questions
- morus bombycis root extract은 임신 중 안전한가요?
- No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR reproductive safety restriction was identified for Morus bombycis (mulberry) root extract, and there are no consistent peer‑reviewed reports showing developmental or reproductive toxicity from topical use; regulatory databases (CosIng, PubChem) list this as a botanical extract without reproductive hazard labels. Therefore default no evidence of reproductive hazard (h=0), no established reproductive mechanism (m=0), and negligible dermal exposure expected for typical cosmetic use (e=0). Sources: ECHA Annex VI (no harmonised classification), CosIng, PubChem, PubMed.
- morus bombycis root extract은 모유 수유 중 안전한가요?
- There are no authoritative assessments (CIR/SCCS/ECHA harmonised) indicating lactation/breastmilk transfer or adverse effects to nursing infants from Morus bombycis root extract, nor peer‑reviewed human data demonstrating transfer via milk; therefore default no evidence of hazard or mechanism (h=0, m=0) and exposure from topical cosmetic use is considered negligible (e=0). Sources: CosIng, PubMed, CIR (no specific assessment found).
- morus bombycis root extract은 아기 피부에 안전한가요?
- No specific infant toxicity or developmental effects were identified (h=0, m=0). Because infant skin has higher permeability and there are no infant‑specific dermal absorption data for this botanical, exposure is increased one category versus adults (e=1) to reflect greater potential percutaneous uptake in 0–3 yr olds for ingredients that are not known to be completely non‑absorbable. Sources: general toxicology principles, CosIng, PubMed.
- VeriMom은 morus bombycis root extract을 어떻게 평가하나요?
- VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 morus bombycis root extract을 100/100 (알려진 위험 없음)로 평가합니다.
- 임신 중 morus bombycis root extract 대체 안전 성분은?
- 유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.
모든 성분표를 2초 만에 확인
VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.
의료 면책 조항
이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.